“Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats”
Article in European Journal of Pharmacology (July 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (July 2024)
Book chapter in Biochemistry (October 2023)
Article in Neurotherapeutics (August 2022)